RICH Statistics

Total Valuation

Laboratorios Richmond S.A.C.I.F. has a market cap or net worth of ARS 150.20 billion. The enterprise value is 278.08 billion.

Market Cap	150.20B
Enterprise Value	278.08B

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Laboratorios Richmond S.A.C.I.F. has 80.75 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	80.75M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	76.96%
Owned by Institutions (%)	0.04%
Float	n/a

Valuation Ratios

The trailing PE ratio is 8.75.

PE Ratio	8.75
Forward PE	n/a
PS Ratio	4.00
PB Ratio	2.48
P/TBV Ratio	n/a
P/FCF Ratio	21.34
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.27, with an EV/FCF ratio of 39.50.

EV / Earnings	16.20
EV / Sales	7.41
EV / EBITDA	22.27
EV / EBIT	21.46
EV / FCF	39.50

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 2.24.

Current Ratio	1.23
Quick Ratio	0.69
Debt / Equity	2.24
Debt / EBITDA	10.95
Debt / FCF	19.43
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 43.62% and return on invested capital (ROIC) is 6.29%.

Return on Equity (ROE)	43.62%
Return on Assets (ROA)	4.98%
Return on Capital (ROIC)	6.29%
Revenue Per Employee	60.56M
Profits Per Employee	27.69M
Employee Count	620
Asset Turnover	0.23
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.23
52-Week Price Change	n/a
50-Day Moving Average	1,244.48
200-Day Moving Average	n/a
Relative Strength Index (RSI)	63.84
Average Volume (20 Days)	38,111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Laboratorios Richmond S.A.C.I.F. had revenue of ARS 37.55 billion and earned 17.17 billion in profits. Earnings per share was 212.59.

Revenue	37.55B
Gross Profit	25.62B
Operating Income	12.96B
Pretax Income	21.35B
Net Income	17.17B
EBITDA	12.49B
EBIT	12.96B
Earnings Per Share (EPS)	212.59

Full Income Statement

Balance Sheet

The company has 9.31 billion in cash and 136.78 billion in debt, giving a net cash position of -127.48 billion or -1,578.61 per share.

Cash & Cash Equivalents	9.31B
Total Debt	136.78B
Net Cash	-127.48B
Net Cash Per Share	-1,578.61
Equity (Book Value)	60.97B
Book Value Per Share	750.05
Working Capital	10.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.13 billion and capital expenditures -1.09 billion, giving a free cash flow of 7.04 billion.

Operating Cash Flow	8.13B
Capital Expenditures	-1.09B
Free Cash Flow	7.04B
FCF Per Share	87.18

Full Cash Flow Statement

Margins

Gross margin is 68.23%, with operating and profit margins of 34.53% and 45.73%.

Gross Margin	68.23%
Operating Margin	34.53%
Pretax Margin	56.87%
Profit Margin	45.73%
EBITDA Margin	33.27%
EBIT Margin	34.53%
FCF Margin	18.75%

Dividends & Yields

Laboratorios Richmond S.A.C.I.F. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.03%
Shareholder Yield	0.03%
Earnings Yield	11.43%
FCF Yield	4.69%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Laboratorios Richmond S.A.C.I.F. has an Altman Z-Score of 0.66. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.66
Piotroski F-Score	n/a